BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ezhilarasan D. Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis. J Cell Physiol 2021. [PMID: 34514599 DOI: 10.1002/jcp.30582] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ezhilarasan D, Najimi M. Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver. Crit Rev Oncol Hematol 2023;182:103902. [PMID: 36621514 DOI: 10.1016/j.critrevonc.2022.103902] [Reference Citation Analysis]
2 Wang P, Lin T, Yang P, Yeh C, Pan T. Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma. IJMS 2022;23:10777. [DOI: 10.3390/ijms231810777] [Reference Citation Analysis]
3 Gao C, Bai J, Han H, Qin H. The versatility of macrophage heterogeneity in liver fibrosis. Front Immunol 2022;13:968879. [DOI: 10.3389/fimmu.2022.968879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Peng Y, Yin Q, Yuan M, Chen L, Shen X, Xie W, Liu J. Role of hepatic stellate cells in liver ischemia-reperfusion injury. Front Immunol 2022;13:891868. [DOI: 10.3389/fimmu.2022.891868] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ro J, Kim J, Cho YK. Recent advances in spheroid-based microfluidic models to mimic the tumour microenvironment. Analyst 2022;147:2023-34. [PMID: 35485712 DOI: 10.1039/d2an00172a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ezhilarasan D, Lakshmi T, Kosuru R. A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/9233650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yu J, Zhang W, Ding D, Hu Y, Guo G, Wang J, Han Y. Bioinformatics Analysis Combined With Experiments Predicts PUDP as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Through Its Interaction With Tumor Microenvironment. Front Oncol 2022;12:830174. [PMID: 35350563 DOI: 10.3389/fonc.2022.830174] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Muriel P. From inflammation to fibrosis. Hepatic Fibrosis 2022. [DOI: 10.1016/b978-0-323-99764-5.00010-x] [Reference Citation Analysis]
9 Muriel P. Cells, cytokines, and factors involved in profibrogenic pathways. Hepatic Fibrosis 2022. [DOI: 10.1016/b978-0-323-99764-5.00014-7] [Reference Citation Analysis]
10 Ge S, Yang W, Chen H, Yuan Q, Liu S, Zhao Y, Zhang J. MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs. Int J Mol Sci 2021;22:12413. [PMID: 34830293 DOI: 10.3390/ijms222212413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ezhilararasan D, Lakshmi T, Raut B, S VK. Novel Nano-Based Drug Delivery Systems Targeting Hepatic Stellate Cells in the Fibrotic Liver. Journal of Nanomaterials 2021;2021:1-9. [DOI: 10.1155/2021/4674046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]